At 68 weeks, the treatment-regimen estimand results were -20.0% (9 mg dose, approximately 50.5 pounds) and -23.7% (12 mg dose, approximately 60 pounds)
When injecting locally near the wrist, move the exact injection point by at least half an inch between doses
It was shown that monocytes from G6PD-deficient AA subjects show a significantly higher peroxide content and increased expression of CD11b compared with those from nondeficient AA subjects
Can you switch to another weight-loss medication instead of stopping treatment
For air travel, the medication should be carried in hand luggage rather than checked baggage to maintain temperature control and prevent loss
STEP 4 was designed as a randomized withdrawal study: every participant first received open-label semaglutide during a 20-week run-in, and only those who completed it were randomized